| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2006-05-17 14:44:52 UTC |
|---|
| Update Date | 2022-09-22 17:45:12 UTC |
|---|
| HMDB ID | HMDB0001913 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Omeprazole |
|---|
| Description | Omeprazole is a highly effective inhibitor of gastric acid secretion used in the therapy of stomach ulcers, dyspepsia, peptic ulcer disease , gastroesophageal reflux disease and Zollinger-Ellison syndrome. The drug inhibits the H(+)-K(+)-ATPase (H(+)-K(+)-exchanging ATPase) in the proton pump of Gastric Parietal Cells.--Pubchem. Omeprazole is one of the most widely prescribed drugs internationally and is available over the counter in some countries. |
|---|
| Structure | COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20) |
|---|
| Synonyms | | Value | Source |
|---|
| Prilosec | Kegg | | ( -)-Omeprazole | HMDB | | (-)-Omeprazole | HMDB | | (S)-(-)-Omeprazole | HMDB | | (S)-Omeprazole | HMDB | | 2,3,5-Trimethylpyridine/Omeprazole | HMDB | | Antra | HMDB | | Antra mups | HMDB | | Audazol | HMDB | | Aulcer | HMDB | | Belmazol | HMDB | | Ceprandal | HMDB | | Danlox | HMDB | | Demeprazol | HMDB | | Desec | HMDB | | Dizprazol | HMDB | | Dudencer | HMDB | | Elgam | HMDB | | Emeproton | HMDB | | Epirazole | HMDB | | Erbolin | HMDB | | Esomeprazole | HMDB | | Esomperazole | HMDB | | Exter | HMDB | | Gasec | HMDB | | Gastrimut | HMDB | | Gastroloc | HMDB | | Gibancer | HMDB | | Indurgan | HMDB | | Inhibitron | HMDB | | Inhipump | HMDB | | Lensor | HMDB | | Logastric | HMDB | | Lomac | HMDB | | Losec | HMDB | | Mepral | HMDB | | Miol | HMDB | | Miracid | HMDB | | Mopral | HMDB | | Morecon | HMDB | | Nexiam | HMDB | | Nexium | HMDB | | Nexium IV | HMDB | | Nilsec | HMDB | | Nopramin | HMDB | | Nuclosina | HMDB | | Ocid | HMDB | | Olexin | HMDB | | Omapren | HMDB | | Omebeta 20 | HMDB | | Omed | HMDB | | Omegast | HMDB | | OMEP | HMDB | | Omepradex | HMDB | | Omepral | HMDB | | Omeprazol | HMDB | | Omeprazole pellets | HMDB | | Omeprazolum | HMDB | | Omeprazon | HMDB | | Omeprol | HMDB | | Omesek | HMDB | | Omez | HMDB | | Omezol | HMDB | | Omezolan | HMDB | | Omid | HMDB | | Omisec | HMDB | | Omizac | HMDB | | Ompanyt | HMDB | | OMZ | HMDB | | Ortanol | HMDB | | Osiren | HMDB | | Ozoken | HMDB | | Paprazol | HMDB | | Parizac | HMDB | | Pepticum | HMDB | | Pepticus | HMDB | | Peptilcer | HMDB | | Prazentol | HMDB | | Prazidec | HMDB | | Prazolit | HMDB | | Prestwick_808 | HMDB | | Prilosec otc | HMDB | | Procelac | HMDB | | Proclor | HMDB | | Prysma | HMDB | | Ramezol | HMDB | | Regulacid | HMDB | | Result | HMDB | | Sanamidol | HMDB | | Secrepina | HMDB | | Tedec ulceral | HMDB | | Ulceral | HMDB | | Ulcesep | HMDB | | Ulcometion | HMDB | | Ulcozol | HMDB | | Ulcsep | HMDB | | Ulsen | HMDB | | Ultop | HMDB | | Ulzol | HMDB | | Victrix | HMDB | | Zefxon | HMDB | | Zegerid | HMDB | | Zepral | HMDB | | Zimor | HMDB | | Zoltum | HMDB | | Magnesium, omeprazole | MeSH, HMDB | | Omeprazole magnesium | MeSH, HMDB | | Omeprazole sodium | MeSH, HMDB | | Sodium, omeprazole | MeSH, HMDB |
|
|---|
| Chemical Formula | C17H19N3O3S |
|---|
| Average Molecular Weight | 345.416 |
|---|
| Monoisotopic Molecular Weight | 345.114712179 |
|---|
| IUPAC Name | 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole |
|---|
| Traditional Name | omeprazole |
|---|
| CAS Registry Number | 73590-58-6 |
|---|
| SMILES | COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C |
|---|
| InChI Identifier | InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20) |
|---|
| InChI Key | SUBDBMMJDZJVOS-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzimidazoles |
|---|
| Sub Class | Sulfinylbenzimidazoles |
|---|
| Direct Parent | Sulfinylbenzimidazoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - Sulfinylbenzimidazole
- Anisole
- Alkyl aryl ether
- Methylpyridine
- Pyridine
- Benzenoid
- Azole
- Imidazole
- Heteroaromatic compound
- Sulfoxide
- Azacycle
- Ether
- Sulfinyl compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 156 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.5 mg/mL | Not Available | | LogP | 2.23 | SANGSTER (1994) |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.18 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.9791 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.42 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1233.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 197.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 142.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 163.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 94.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 424.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 379.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 675.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 715.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 168.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 823.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 199.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 300.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 477.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 167.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 90.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Omeprazole,1TMS,isomer #1 | COC1=CC=C2N=C(S(=O)CC3=NC=C(C)C(OC)=C3C)N([Si](C)(C)C)C2=C1 | 3109.7 | Semi standard non polar | 33892256 | | Omeprazole,1TMS,isomer #1 | COC1=CC=C2N=C(S(=O)CC3=NC=C(C)C(OC)=C3C)N([Si](C)(C)C)C2=C1 | 2949.4 | Standard non polar | 33892256 | | Omeprazole,1TMS,isomer #1 | COC1=CC=C2N=C(S(=O)CC3=NC=C(C)C(OC)=C3C)N([Si](C)(C)C)C2=C1 | 4035.5 | Standard polar | 33892256 | | Omeprazole,1TBDMS,isomer #1 | COC1=CC=C2N=C(S(=O)CC3=NC=C(C)C(OC)=C3C)N([Si](C)(C)C(C)(C)C)C2=C1 | 3236.5 | Semi standard non polar | 33892256 | | Omeprazole,1TBDMS,isomer #1 | COC1=CC=C2N=C(S(=O)CC3=NC=C(C)C(OC)=C3C)N([Si](C)(C)C(C)(C)C)C2=C1 | 3179.0 | Standard non polar | 33892256 | | Omeprazole,1TBDMS,isomer #1 | COC1=CC=C2N=C(S(=O)CC3=NC=C(C)C(OC)=C3C)N([Si](C)(C)C(C)(C)C)C2=C1 | 4006.4 | Standard polar | 33892256 |
|
|---|